Home › Sjögren's Disease › Florida › Clearwater
Sjögren's Disease clinical trials in Clearwater, FL
4 studies for Sjögren's Disease are looking for participants at sites in and around Clearwater (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Phase 2a/b Study to Assess the Efficacy, Safety and Tolerability of DDY391 in Participants With Sjögren's Disease
RecruitingPhase 2
- Clinical Res Of W Florida, Clearwater
Two Arm, Double-blind, Phase III Study Assessing Efficacy and Safety of Ianalumab Versus Placebo, in Participants With Sjögren's Disease With High Symptom Burden
RecruitingPhase 3
- Clinical Res Of W Florida, Clearwater
Phase 3 Study of Telitacicept in Active Primary Sjögren's Disease
RecruitingPhase 3
- Clinical Research of West Florida - Corporate, Clearwater
- Clinical Research of West Florida, Inc., Clearwater
A Long-term Extension Study of Dazodalibep in Participants With Sjögren's Syndrome (SS)
RecruitingPhase 3
- Clinical Research of West Florida Inc - Clearwater, Clearwater
About Sjögren's Disease
Sjögren's disease is an autoimmune disease that causes dryness of the mouth, eyes, and other parts of the body. Learn how to relieve the symptoms.
More about Sjögren's Disease on MedlinePlus
Sjögren's Disease trials in other cities
- Washington, DC6 studies
- Houston, TX6 studies
- Boston, MA5 studies
- Tampa, FL4 studies
- Cicero, IL4 studies
- Arlington, TX4 studies
- Charlotte, NC4 studies
- Oklahoma City, OK3 studies
- Memphis, TN3 studies
- Philadelphia, PA3 studies
- Chicago, IL3 studies
- Orlando, FL3 studies
Other studies in Clearwater
- Cardiovascular Disease9 studies
- Lupus7 studies
- Obesity7 studies
- Overweight6 studies
- Heart Failure6 studies
- Breast Cancer6 studies
- Coronary Artery Disease5 studies
- Rheumatoid Arthritis5 studies
- Atrial Fibrillation5 studies
- Non-Small Cell Lung Cancer5 studies
- Lung Cancer4 studies
- Type 2 Diabetes4 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.